Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis
People with chronic schizophrenia die on average 10-15 years sooner than the general population, mostly due to physical comorbidity. While sociodemographic, chronic lifestyle and iatrogenic factors are important contributors to this comorbidity, a growing body of research is beginning to suggest that early signs of cardiometabolic dysfunction may be present from the onset of psychosis in some young adults, and may even be detectable before the onset of psychosis. Given that primary prevention is the best means to prevent the onset of more chronic and severe cardiometabolic phenotypes such as CVD, there is clear need to be able to identify young adults with psychosis who are most at risk of future adverse cardiometabolic outcomes, such that the most intensive interventions can be directed in an informed way to attenuate the risk or even prevent those adverse outcomes from occurring.

Young people with psychosis are at high risk of developing cardiometabolic disorders; however, there is no suitable cardiometabolic risk prediction algorithm for this group. We aimed to develop and externally validate a cardiometabolic risk prediction algorithm for young people with psychosis.
Date: 19 October 2021, 15:00 (Tuesday, 2nd week, Michaelmas 2021)
Venue: virtual via Zoom
Speaker: Dr Benjamin Perry (University of Cambridge)
Organising department: Department of Psychiatry
Organiser: Dr Andrey Kormilitzin (University of Oxford)
Organiser contact email address: andrey.kormilitzin@psych.ox.ac.uk
Host: Dr Andrey Kormilitzin (University of Oxford)
Part of: Artificial Intelligence for Mental Health Seminar Series
Booking required?: Not required
Booking email: andrey.kormilitzin@psych.ox.ac.uk
Audience: Public
Editor: Andrey Kormilitzin